Sumei Z. Wang
The Postdoctoral Research Station
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Di-2-ethylhexyl Phthalate Reprograms Epithelial-Mesenchymal Transition and Lenvatinib Responsiveness in Hepatoma Cells via SPAG4-Dependent MAPK/ERK Signaling.
Journal: Chemical research in toxicology
Published: May 13, 2026
The regulatory role of lncRNA-LOC680225 in fluoride-induced neurotoxicity: Insights into the miR-194-5p/Slc5a7 signaling axis.
Journal: Ecotoxicology and environmental safety
Published: April 26, 2026
Fuzheng Kang'ai Formula suppresses NSCLC by inducing a functional crosstalk between autophagy and ferroptosis via EZH2/DOT1L/H3K79me2 signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 13, 2025
Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms.
Journal: Clinical epigenetics
Published: March 21, 2025
Mechanisms of drug resistance in hepatocellular carcinoma.
Journal: Biological procedures online
Published: January 22, 2025
Polyphyllin I induces ferritinophagy dependent ferroptosis through EZH2 and promotes anti-tumor immunity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 19, 2025
Tumor Prognostic Risk Model Related to Monocytes/Macrophages in Hepatocellular Carcinoma Based on Machine Learning and Multi-Omics.
Journal: Biological procedures online
Published: December 10, 2024
Decoding the possible mechanism of action of Paeoniflorigenone in combating Aflatoxin B1-induced liver cancer: an investigation using network pharmacology and bioinformatics analysis.
Journal: Toxicology mechanisms and methods
Published: October 01, 2024
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 11, 2024
Efficacy and Safety of Huachansu as an Adjuvant Therapy for Non-Small Cell Lung Cancer: An Overview of Systematic Reviews and Meta-Analyses.
Journal: Integrative cancer therapies
Published: March 12, 2024
Last Updated: 09/26/2026